Cargando…
Vestibular Evoked Myogenic Potential (VEMP) Triggered by Galvanic Vestibular Stimulation (GVS): A Promising Tool to Assess Spinal Cord Function in Schistosomal Myeloradiculopathy
BACKGROUND: Schistosomal myeloradiculopathy (SMR), the most severe and disabling ectopic form of Schistosoma mansoni infection, is caused by embolized ova eliciting local inflammation in the spinal cord and nerve roots. The treatment involves the use of praziquantel and long-term corticotherapy. The...
Autores principales: | Caporali, Júlia Fonseca de Morais, Utsch Gonçalves, Denise, Labanca, Ludimila, Dornas de Oliveira, Leonardo, Vaz de Melo Trindade, Guilherme, de Almeida Pereira, Thiago, Diniz Cunha, Pedro Henrique, Santos Falci Mourão, Marina, Lambertucci, José Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851389/ https://www.ncbi.nlm.nih.gov/pubmed/27128806 http://dx.doi.org/10.1371/journal.pntd.0004672 |
Ejemplares similares
-
Correction: Vestibular Evoked Myogenic Potential (VEMP) Triggered by Galvanic Vestibular Stimulation (GVS): A Promising Tool to Assess Spinal Cord Function in Schistosomal Myeloradiculopathy
por: Caporali, Júlia Fonseca de Morais, et al.
Publicado: (2016) -
Vestibular evoked myogenic potential (VEMP) with galvanic stimulation in normal subjects
por: Cunha, Luciana Cristina Matos, et al.
Publicado: (2014) -
Intrarater and interrater agreement and reliability of vestibular evoked myogenic potential triggered by galvanic vestibular stimulation (galvanic-VEMP) for HTLV-1 associated myelopathy testing
por: Caporali, Júlia Fonseca de Morais, et al.
Publicado: (2018) -
Ocular vestibular evoked myogenic potential (VEMP) reveals mesencephalic HTLV-1-associated neurological disease
por: Silva, Tatiana Rocha, et al.
Publicado: (2019) -
Vestibular-evoked myogenic potential triggered by galvanic vestibular stimulation may reveal subclinical alterations in human T-cell lymphotropic virus type 1-associated myelopathy
por: Labanca, Ludimila, et al.
Publicado: (2018)